mortality/aging
• reduced life span
• early-onset Sodium Butyrate (SB, a HDAC inhibitor) treatment (from 4 weeks old) extends their average life span (13.7%)
• late-onset (from 12 weeks old) SB treatment extends the average life span (21.5%)
|
nervous system
• neurons in the dentate cerebellar nucleus display somal atrophy
|
• extensive nuclear accumulation of Atrophin-1 and widespread nuclear inclusions in several brain regions (striatum, cortex, thalamus, red nucleus, dentate cerebellar nucleus, and Purkinje cells)
|
behavior/neurological
• progressively lose the capability to coordinate and balance in the rotarod test and the hanging wire test
• early-onset Sodium Butyrate (SB, a HDAC inhibitor) treatment (from 4 weeks old) delays the onset of motor impairments
|
reproductive system
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
dentatorubral-pallidoluysian atrophy | DOID:0060162 |
OMIM:125370 |
J:112706 |